Amgen is an American biotechnology company founded in 1980 and headquartered in Thousand Oaks, California. Its name is a contraction of Applied Molecular Genetics, the company's original name. Amgen develops and manufactures biologic medicines produced with recombinant DNA technology and is regarded as one of the largest independent biotechnology companies in the world.
Its best-known products include Epogen for anemia, Neupogen and Neulasta for neutropenia, Enbrel for rheumatoid arthritis, Prolia for osteoporosis, and Repatha for high cholesterol. The company focuses on oncology, inflammation, cardiovascular and bone diseases, and its shares are listed on NASDAQ.